Home
Conditions
Lymphoproliferative Disorders

Clinical trial condition

Lymphoproliferative Disorders

Explore clinical trials studying Lymphoproliferative Disorders. Study availability and eligibility vary by location and protocol.

10,146 public trials 2,034 recruiting studies

Refine in advanced search Browse all conditions

Lymphoproliferative Disorders trial results

Not yet recruiting

Low Dose, Reduced Frequency Nivolumab for the Treatment of Unresectable or Metastatic Cancer, AFFORD IO Trial

NCT07576725

Conditions: Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +119 more
Locations: Uganda Cancer Institute Kampala, Uganda

View Trial Details

Not yet recruiting

Real World Asparaginase Therapy Toxicity

NCT07008027

Conditions: Chemically-Induced Disorders, Drug Toxicity, Drug-Related Side Effects and Adverse Reactions, +12 more
Locations: St. Jude Children's Research Hospital Memphis, Tennessee, United States

View Trial Details

Not yet recruiting

CBC-Based Inflammatory Indices in Newly Diagnosed Multiple Myeloma

NCT07823959

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: Not specified

View Trial Details

Not yet recruiting

A Study Evaluating Subcutaneous Versus Intravenous Blinatumomab in Newly Diagnosed Adults With B-cell Precursor Acute Lymphoblastic Leukaemia

NCT07223190

Conditions: Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations: Not specified

View Trial Details

Not yet recruiting

variaTIon in Referral Thresholds in the Chronic Lymphocytic LeukaEmia Pathway

NCT07463976

Conditions: Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +17 more
Locations: The Royal Wolverhampton NHS Trust Wolverhampton, United Kingdom

View Trial Details

Not yet recruiting

Psilocybin-assisted Existential, Attachment and RelationaL (PEARL) Therapy for Patients With Advanced Cancer: A Randomized Controlled Trial

NCT07820033

Conditions: Advanced Cancer, Endocrine Cancer, Endocrine Gland Neoplasms, +28 more
Locations: University Health Network Toronto, Ontario, Canada

View Trial Details

Not yet recruiting

Phase II Study of the Combination of Subcutaneous Blinatumomab and Olverembatinib in Patients With Philadelphia Chromosome (ph)-Positive and/or BCR::ABL1 Positive Acute Lymphoblastic Leukemia (ALL)

NCT07178912

Conditions: Blinatumomab, Hematologic Diseases, Hemic and Lymphatic Diseases, +13 more
Locations: MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Not yet recruiting

Tafasitamab and Rituximab for the Treatment of Newly Diagnosed Follicular Lymphoma

NCT07731789

Conditions: Classic Follicular Lymphoma, Grade 1 Follicular Lymphoma, Grade 2 Follicular Lymphoma, +11 more
Locations: Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States

View Trial Details

Not yet recruiting

Study of Zanubrutinib in Older Patients With Previously Untreated Chronic Lymphocytic Leukemia (CLL)

NCT07739459

Conditions: Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +15 more
Locations: Chu Lyon-Sud Lyon, Pierre Bénite, France

Ch Victor Dupouy Argenteuil, France

Ch D'Avignon - Hopital Henri Duffaut Avignon, France

Ch de La Cote Basque Bayonne, France

View all 17 locations

View Trial Details

Not yet recruiting

A Study of BL-M08D1 in Combination With Immunochemotherapy in Patients With Diffuse Large B-Cell Lymphoma

NCT07818499

Conditions: Diffuse Large B-cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations: Sun Yat-sen University Cancer Center Guangzhou, Guangdong, China

The First Affiliated Hospital of Soochow University Suzhou, Jiangsu, China

View Trial Details

Lymphoproliferative Disorders

Lymphoproliferative Disorders trial results

Related conditions